Pulmonary Embolism Models

Catheterization | DVT-CAVT Simulation Technique

About Endovascular Venous model

Our bench-top and full-scale Pulmonary Embolism models offer customizable, closed-loop systems that closely replicate real-world conditions. Models can demonstrate the Deep Vein Thrombosis (DVT) to Computer Assisted Vacuum Thrombectomy (CAVT) technique on our realistic endovascular simulation model, designed for training and procedural testing.

Types

Full Scale
Block Model
3D Model
Reusable
Perfusion Closed-loop System
Angio-Compatible
Ultra Transparent
Optical Navigation Compatible

Clots can be injected at multiple sites to simulate various scenarios

Portable: Easy to carry

Specific Details

Models Suitable for

Computer Assisted Vacuum Thrombectomy (CAVT)
Deep Vein Thrombosis (DVT)

Training and Testing Capabilities

Master catheter navigation
Understand clot dynamics and intervention outcomes
Thrombectomy techniques in a safe, repeatable environment

Showcase how effectively your catheter minimizes blood loss in the simulation model !

To book a demo and to know more Click here

Complete the form for sales, inquiries, or assistance

contact-us-map

Contact us

Frequently asked questions

These are the most commonly asked questions. can't find what you are looking for use our chatbot.

  • What is the best treatment for pulmonary embolism?

    Prompt anticoagulation with medications like low-molecular-weight heparin or direct oral anticoagulants forms the foundation of pulmonary embolism treatment, adhering to current guidelines. Thrombolytic therapy or catheter-based clot aspiration systems are essential for massive or high-risk acute pulmonary embolism cases. Long-term care centers on deep vein thrombosis medication to prevent recurrence and chronic pulmonary embolism.
  • What is the purpose of the pulmonary embolism (PE) simulation model?

    The pulmonary embolism simulation model trains clinicians to master pulmonary embolism surgical simulation, covering diagnosis using CT scans and advanced catheter-based treatment. It accurately recreates blood clot simulation in a realistic cardiovascular system clotting environment, enabling hands-on practice with clot removal systems, catheter-directed thrombolysis, and deep vein thrombosis medical devices, resulting in enhanced procedural proficiency and improved patient safety.
  • What is the survival rate for pulmonary embolism?

    Survival hinges on the severity of embolism and comorbidities. In-hospital mortality for untreated acute pulmonary embolism stands at 10–30%. However, prompt treatment ensures survival rates exceed 90%. Accurate diagnosis, usually via a pulmonary embolism CT scan, and swift administration of medication or interventional clot removal radically improve outcomes.
  • Can you fully recover from a pulmonary embolism?

    Patients fully recover with effective pulmonary embolism treatment, which includes anticoagulation and, when necessary, catheter-based clot aspiration or surgery. By following pulmonary embolism guidelines and taking preventive measures with deep vein thrombosis medication, we significantly reduce the risk of chronic pulmonary embolism and long-term complications, enabling patients to return to their normal activities.
  • What is the first line of treatment for pulmonary embolism?

    Anticoagulation is the primary treatment: we start with low-molecular-weight heparin or a direct oral anticoagulant unless it's contraindicated. In massive or submassive cases with hemodynamic instability, we proceed with thrombolysis or catheter-based pulmonary embolism treatment, such as a clot removal system or pulmonary embolism surgery, after confirming the diagnosis with a pulmonary embolism CT scan.
  • What are the potential complications of pulmonary embolism?

    Complications of pulmonary embolism include developing pulmonary hypertension, right ventricular dysfunction, and post-thrombotic syndrome, as well as experiencing recurrent deep vein thrombosis. Inadequate or delayed treatment necessitates surgery or long-term medication. Anticoagulation or thrombolysis can cause hemorrhagic complications in some patients.
  • How is pulmonary embolism diagnosed?

    Diagnosis depends on a thorough clinical assessment and imaging. We deploy D-dimer testing, Doppler ultrasound to detect deep vein thrombosis, and contrast-enhanced pulmonary embolism CT scans to visualize clots. Ventilation-perfusion scanning, echocardiography, and right heart catheterization identify acute and chronic pulmonary embolism.
  • What is deep vein thrombosis in medicine?

    Deep vein thrombosis (DVT) forms when a blood clot develops in a deep vein, typically in the legs. It dislodges and travels to the lungs, causing pulmonary embolism. We treat DVT with medication, specifically anticoagulants, and use compression stockings, thrombectomy, or medical devices to prevent embolization.
  • What questions should I ask a patient with DVT?

    Identify the following crucial details: when leg swelling or pain started and how long it has lasted, any recent instances of immobility or surgery, family members who have had clotting issues, current or past use of deep vein thrombosis medication, and symptoms that could indicate pulmonary embolism, such as chest pain or dyspnea. Evaluate risk factors according to pulmonary embolism guidelines, taking into account cancer, oral contraceptives, or clotting disorders.
  • What is the Pulmonary Embolism Simulation Model?

    Our Pulmonary Embolism Simulation Model delivers realistic, high-fidelity training in acute pulmonary embolism scenarios. This innovative tool simulates blood clots within a cardiovascular system, mirroring real-world clotting environments and seamlessly integrating with pulmonary embolism CT scan data and navigation systems. It enables hands-on practice of catheter-based clot removal systems and pulmonary embolism surgical simulation.
  • What are the different types of pulmonary embolism?

    Pulmonary embolism falls into three distinct categories: massive (hemodynamically unstable), submassive (RV dysfunction without shock), and low-risk (stable vital signs). Chronic pulmonary embolism develops when unresolved emboli causes pulmonary hypertension. We replicate each scenario, from acute to chronic pulmonary embolism, using our advanced 3D simulation platform in training.
  • How long can a pulmonary embolism go untreated?

    Untreated small emboli can remain symptom-free for days, but massive pulmonary embolism can kill within hours if left untreated. Chronic pulmonary embolism develops over weeks to months. Our model stresses the importance of prompt pulmonary embolism treatment and the devastating effects of delays on outcomes.
  • What is the greatest risk for pulmonary embolism?

    Deep vein thrombosis is the highest risk factor, commonly triggered by immobilization, surgery, or cancer. Inherited thrombophilias, oral contraception, obesity, and prolonged travel also pose significant risks. We must deploy effective medications and medical devices to prevent pulmonary embolism and reduce these risks.
  • What is the life expectancy of a person with a pulmonary embolism?

    Life expectancy significantly improves. Rapid pulmonary embolism treatment and strict adherence to guidelines enable most patients to regain normal life expectancy. Chronic or recurrent pulmonary embolism drastically reduces survival rates. Our model empowers clinicians to pinpoint optimal medication and surgical interventions, ensuring superior long-term outcomes.
  • How do you categorize pulmonary embolism?

    We classify pulmonary embolism into three categories based on hemodynamic impact and RV function: massive, which causes shock; submassive, which causes RV strain; and low-risk, which is stable. Chronic pulmonary embolism is a distinct category, marked by persistent perfusion defects and pulmonary hypertension. Our simulation model covers all categories, providing comprehensive training.
  • What are the three types of pulmonary embolism?

    The three clinical types of pulmonary embolism are categorized as massive, resulting in hypotension; submassive, causing RV dysfunction without hypotension; and low-risk, where the patient remains stable. Chronic pulmonary embolism with pulmonary hypertension is classified separately. Our 3D embolism training model accurately depicts each distinct pathophysiology.
  • What is the best medication for deep vein thrombosis?

    We treat first-line deep vein thrombosis with DOACs (apixaban, rivaroxaban) or low-molecular-weight heparin. Renal function, bleeding risk, and patient factors determine the best option. Our pulmonary embolism simulation accurately models anticoagulant effects, enabling effective dosing and monitoring training.
  • What are the treatment options for a DVT?

    DVT treatment options comprise anticoagulation with heparin or DOACs, compression therapy, and targeted catheter-directed thrombolysis or thrombectomy using advanced deep vein thrombosis medical devices. Our model seamlessly combines DVT scenarios with pulmonary embolism risk, effectively demonstrating embolization prevention.
  • How much does it cost to treat a pulmonary embolism?

    Treatment costs differ significantly depending on severity, region, and modality. Anticoagulation using DOACs costs a few hundred dollars per month. In contrast, thrombolysis, catheter-based interventions, or pulmonary embolism surgery cost between $10,000 and $25,000 USD. Check your facility's billing for exact deep vein thrombosis and pulmonary embolism procedure prices.
  • What is the CPT code for pulmonary embolism?

    Pulmonary embolism imaging relies on CPT 71260-71270 for CT pulmonary angiography. Therapeutic codes are 37184 for percutaneous mechanical thrombectomy and 37211 for vascular infusion in thrombolysis. CPT 35475 covers venous thrombectomy for DVT. Consult payer guidelines for billing of deep vein thrombosis medical devices.
  • What are deep vein thrombosis and pulmonary embolism?

    Deep vein thrombosis causes clots to form in deep veins, typically in the legs. When a clot breaks loose and travels to pulmonary arteries, it becomes a pulmonary embolism, causing impaired gas exchange and putting patients at risk of hemodynamic collapse. We treat deep vein thrombosis with medication and, in critical cases, employ advanced pulmonary embolism surgical simulation interventions.
  • What is the treatment option for PE?

    Our pulmonary embolism model simulates seven treatment options: anticoagulation, systemic thrombolysis, catheter-directed thrombolysis, clot removal systems, clot aspiration systems, ischemic stroke-style devices, and pulmonary embolism surgery. We provide hands-on simulation for each.
  • What is the billing code for DVT?

    DVT management codes comprise 93970 for noninvasive extremity venous studies and 35470-35475 for venous thrombectomy. Catheter-directed thrombolysis codes are 37002-37004. Confirm coverage for "deep vein thrombosis medical devices" with payers.
  • What are the medical devices for deep vein thrombosis?

    Devices comprise vena cava filters, mechanical thrombectomy catheters, and clot aspiration systems, which are often used beyond their approved indications for pulmonary embolism simulation and removal. Our model enables practitioners to hone their skills with these deep vein thrombosis medical devices and pulmonary embolism device workflows.
  • How much does deep vein thrombosis surgery cost?

    Surgical thrombectomy for DVT costs between $8,000 and $15,000 USD, driven by complexity and facility. Catheter-directed interventions cost $12,000 to $20,000 USD. Regional, equipment, and device fees drive cost variations.
  • What is the best diagnostic tool for pulmonary embolism?

    CT pulmonary angiography is the definitive test for diagnosing pulmonary embolism. If CT is not possible, V/Q scans offer a suitable alternative. Our simulation program teaches learners to expertly interpret both tests and make informed decisions, ensuring compliance with pulmonary embolism guidelines.
  • How much does it cost to treat a pulmonary embolism?

    Treatment costs range from $800 to $4,000 per month for anticoagulation therapy, $12,000 to $20,000 for thrombolysis or catheter-directed interventions, and over $16,000 for surgery. Facility fees, device charges, and regional differences increase these costs. Verify the exact cost with your billing office.

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site.

Necessary Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

Advertisement

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

Uncategorized

Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.